swarnali Das Paul

About

Dr. Swarnali Das Paul, M. Pharm (Pharmaceutics), Ph.D., is the Director of Shri Shankaracharya College of Pharmaceutical Sciences (SSCPS), Bhilai, Chhattisgarh, and Dean, Life Sciences at Shri Shankaracharya Professional University (SSPU). She also serves as Convenor of the IQAC & IPR Cell, Head of the Internal Compliance Committee, and member of the Academic Council at SSPU, in addition to her roles as Inspector for the Pharmacy Council of India (PCI) and Chhattisgarh Swami Vivekanand Technical University (CSVTU).
With over 17 years of academic and research experience, Dr. Paul has authored 49 research publications, 12 patents, 7 books, and 6 book chapters, and has supervised more than 25 M.Pharm and Ph.D. scholars. She has secured 3 research grants and 4 conference grants, and has been honored with six awards, including Young Achiever (Dubai, 2019), Pharma Woman of Chhattisgarh (2021), and Excellence in Research (2023, 2024).
Her major research contributions include establishing the ADR Monitoring Center at SSCPS under the Pharmacovigilance Programme of India, and leading the “Iron Bindi” Project under the PRAYAS Scheme of IBITF, IIT Bhilai—a novel transdermal iron supplementation system. She has also successfully led projects funded by DST–IEDC and CGCOST, with a strong focus on nanotechnology-based drug delivery systems for inflammatory diseases, cancer therapy, ocular, and transdermal applications.
Dr. Paul is an active collaborator across pharmacy, biotechnology, and biomedical engineering, and has chaired or delivered sessions in over 50 national and international conferences, demonstrating her commitment to advancing pharmaceutical education, research, and public health.

Employment

• SSCPS Director
  2019 - Present
• Shri Gangajali Education Society associate professor
  2010 - 2019
• Narsee Monjee Institute of Management Studies University Assistant Professor
  2008 - 2010

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (21)

• Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease
  Journal of Drug Delivery Science and Technology 2020 DOI: 10.1016/j.jddst.2019.101495
  +Save
• Safety and Toxicity Counts of Nanocosmetics
  Nanocosmetics 2019 DOI: 10.1007/978-3-030-16573-4_14
  +Save
• Emerging Potential of In Vitro Diagnostic Devices: Applications and Current Status
  Medicinal Chemistry with Pharmaceutical Product Development 2019 DOI: 10.1201/9780429487842-9
  +Save
• Rheumatiod arthritis: An updated overview of latest therapy and drug delivery
  Journal of Pharmacopuncture 2019 DOI: 10.3831/KPI.2019.22.029
  +Save
• Solubility augmentation of simvastatin by using the marvelous carrier hydroxy propyl β-cyclodextrin: Compatibility study, statistical and spectral analysis
  Indian Journal of Pharmaceutical Education and Research 2019 DOI: 10.5530/ijper.53.3s.92
  +Save
• Advances in the delivery of cancer therapeutics: A comprehensive review
  Current Drug Delivery 2018 DOI: 10.2174/1567201814666170726105219
  +Save
• Recent Advances in the Delivery of Chemotherapeutic Agents
  Nano- and Microscale Drug Delivery Systems 2017 DOI: 10.1016/b978-0-323-52727-9.00015-7
  +Save
• Recent Advances in the Delivery of Chemotherapeutic Agents
  Nano- and Microscale Drug Delivery Systems: Design and Fabrication 2017 DOI: 10.1016/B978-0-323-52727-9.00015-7
  +Save
• Novel gels: implications for drug delivery
  Nanostructures for Drug Delivery 2017 DOI: 10.1016/b978-0-323-46143-6.00012-9
  +Save
• Preparation and In Vitro Evaluation of an Anti-bacterial In Situ Ophthalmic Gel
  Current Nanomedicine 2017 DOI: 10.2174/2468187306666160927115945
  +Save